Statistics
Publications
20
Citations
735
H-Index
16
Active since
2005
Hongbing Zhang is an author at Tianjin Medical University General Hospital specializing in medicine, molecular oncology, and oncology.
Publications per year
2005–2025
20
20
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells
Hao Gong, Yuan Yin, Weiting Li et al. · BMC Cancer · 2020 · 68 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 20